ANIK - Anika Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue113,420103,37992,999105,595
Cost of Revenue27,36424,02721,05320,930
Gross Profit86,05679,35271,94684,665
Operating Expenses
Research Development18,78710,7328,2908,144
Selling General and Administrative21,54018,01314,82515,074
Non Recurring----
Total Operating Expenses67,69152,77244,16844,148
Operating Income or Loss45,72950,60748,83161,447
Income from Continuing Operations
Total Other Income/Expenses Net473263-57758
Earnings Before Interest and Taxes45,72950,60748,83161,447
Interest Expense----
Income Before Tax46,20250,87048,25461,505
Income Tax Expense14,38618,32317,49623,186
Minority Interest----
Net Income From Continuing Ops31,81632,54730,75838,319
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income31,81632,54730,75838,319
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares31,81632,54730,75838,319